Magnesium in PDB 9ex9: Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase

All present enzymatic activity of Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase:
2.7.7.6;

The structure of Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase also contains other interesting chemical elements:

Zinc

(Zn)

4 atoms

The binding sites of Magnesium atom in the Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase (pdb code 9ex9). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase, PDB code: 9ex9:

Magnesium binding site 1 out of 1 in the Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Cryo Em Map and Model of the Vaccinia Minimal Rna Polymerase within 5.0Å range: probe atom residue distance (Å) B Occ A:Mg1301 b:81.8 occ:1.00 OD1 A:ASP417 1.9 95.6 1.0 OD1 A:ASP419 2.2 92.2 1.0 OD1 A:ASP415 2.5 93.6 1.0 CG A:ASP417 2.6 89.4 1.0 OD2 A:ASP417 2.7 88.5 1.0 CG A:ASP419 3.2 83.7 1.0 CG A:ASP415 3.4 90.3 1.0 OD2 A:ASP419 3.5 83.9 1.0 OD2 A:ASP415 3.5 102.0 1.0 H A:ASP417 3.8 85.2 1.0 HB2 S:ASN226 3.9 80.5 1.0 H S:ASN226 4.1 79.7 1.0 CB A:ASP417 4.1 84.1 1.0 H A:ASP419 4.2 85.7 1.0 O S:ASN226 4.3 85.0 1.0 H A:ASP415 4.5 82.0 1.0 N A:ASP419 4.5 87.0 1.0 N A:ASP417 4.5 83.8 1.0 CB A:ASP419 4.5 80.0 1.0 HB3 A:ASP417 4.5 86.0 1.0 C A:ASP417 4.6 88.4 1.0 HB2 A:ASP417 4.6 86.3 1.0 CA A:ASP417 4.6 82.1 1.0 HD22 S:ASN226 4.7 82.7 1.0 N A:GLY418 4.7 82.2 1.0 HA A:ASP419 4.7 85.2 1.0 HH21 A:ARG380 4.8 82.3 1.0 CB A:ASP415 4.8 80.9 1.0 H A:GLY418 4.8 84.0 1.0 CB S:ASN226 4.8 80.0 1.0 N S:ASN226 4.8 76.1 1.0 O A:ASP415 4.8 89.0 1.0 CA A:ASP419 4.9 84.8 1.0 O A:ASP417 4.9 97.2 1.0 HB2 A:ASP419 4.9 81.9 1.0 C A:ASP415 5.0 80.4 1.0

C.Grimm, S.Jungwirth, U.Fischer. Cryo Em Map and Model of the Vaccinia Rna Polymerase Intermediate Pre-Initiation Open Promoter Complex (Casp Target) To Be Published.